Volume: 44 Suppl: 2 - September 2016
| INVITED REVIEW | |
| 1. | Clinical pharmacology of the apixaban and frequently asked questions about its clinical use Adnan Abacı Pages 1 - 6 |
| 2. | Protection in atrial fibrillation Lale Tokgözoğlu, Bülent Görenek Pages 7 - 13 |
| 3. | ARISTOTLE study and sub-group analyses: Conspicuous points Özgür Aslan Pages 14 - 25 |
| 4. | The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy Mesut Demir Pages 26 - 32 |
| 5. | Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies? Necla Özer Pages 33 - 40 |
| 6. | Venous thromboembolism studies of apixaban and its clinical use A. Kürşat Bozkurt Pages 41 - 46 |
Journal Metrics
Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348
Quick Search
Copyright © 2026 Archives of the Turkish Society of Cardiology
Kare Publishing is a subsidiary of Kare Media.